April 2025
02 Jun 2025
The global digital breast tomosynthesis equipment market revenue surpassed USD 4.62 billion in 2025 and is predicted to attain around USD 13.75 billion by 2033, growing at a CAGR of 14.31%. The growth of the market is attributed to the increased prevalence of breast cancer around the world.
The digital breast tomosynthesis equipment market is growing at a significant rate, primarily due to the increased awareness among the population about early detection of breast cancer. Unlike 2-dimensional (2D) imaging used by mammogram systems, digital breast tomosynthesis (DBT) provides high-resolution images of breast tissue, resulting in increased cancer detection rates and fewer false positives. The potential for improved diagnostics capacity continues to drive widespread uptake in diagnostic centers and hospitals. Increased awareness about breast health and initiatives by many governments and health systems encouraging early routine screening are further stimulating the growth of this market.
Additionally, continuous innovation in the digital tomosynthesis space, including the development of artificial intelligence solutions to improve interpretation and workflow, is changing the landscape of breast cancer diagnostics. Larger manufacturers are investing heavily in R&D to develop sophisticated digital tomosynthesis systems with better sensitivity, usability, or lower cost. As patient demand for advanced imaging equipment continues to grow, the market for digital breast tomosynthesis equipment ill increase steadily.
Technological Advancements
Technological advancements open new growth avenues for the market. Integrating artificial intelligence AI in digital breast tomosynthesis systems significantly improves the accuracy of diagnosis. Companies such as GE Healthcare have been launching AI-augmented tools like the MyBreastAI suite that assist radiologists in reducing the complexity of interpreting digital breast tomosynthesis images and thus improve early detection rates. Moreover, integrating DBT with other diagnostic tools, such as automated breast ultrasound and molecular imaging, can improve diagnostic accuracy and expand market opportunities.
Strategic Partnerships and Acquisitions
In order to grow the market and offer more products, companies are utilizing various business development strategies such as partnerships and acquisitions. Partnerships and acquisitions between market players expand market reach, share technological advancements, and consolidate market positions, leading to increased innovation and growth. For example, Hologic’s recent acquisition of Endomagnetics Ltd. intended to get surgical tools into the Hologic portfolio for treating breast cancer.
Emphasis on Patient-Centric Care
As awareness about breast cancer continues to rise, there will be a high demand for a patient-centric care approach. The use of DBT in personalized medicine approaches, such as tailoring screening protocols based on individual risk factors, can create new market opportunities. Several campaigns are focusing on informing the public regarding early detection and the critical role of digital breast tomosynthesis in improving patient outcomes. Educational campaigns and awareness initiatives provide patients with information about the advantages of advanced technologies that enhance patient outcomes, creating the need for personalized care approaches.
Product Insights
The standalone 3D system segment led the market with the largest share in 2024. This is mainly due to the increased demand for advanced diagnostic solutions for diagnosing breast diseases. The standalone 3D system is considered an advanced solution, which brought modification in mammography. This system allows for tumour detection, where the obscuring impact of covering breast tissue is eliminated. It allows radiologists to take images from different angles to determine any potential malignancy by looking at several images. It is less likely to provide false outcomes due to its high accuracy, combined with 3D mammography. As cancer incidences increase, a prompt diagnosis is considered important.
End-User Insights
The hospitals segment dominated the market with the largest share in 2024 and is expected to continue its upward trajectory during the forecast period. Because hospitals provide specialized treatments and have dedicated teams of skilled doctors, nurses, and support staff, cancer patients often prefer to receive treatment in these settings. On the other hand, the diagnostic centers segment is projected to grow at the fastest CAGR in the coming years. This is mainly due to the increasing patient volumes in these settings undergoing diagnostic procedures.
North America held the largest revenue share of the digital breast tomosynthesis equipment market in 2024. This is mainly due to the presence of well-developed healthcare facilities and diagnostic centers. There is a heightened adoption of advanced diagnostic solutions. Rising government programs that support screening further support the long-term growth of the market.
Asia Pacific is expected to grow at the highest CAGR during the forecast period. This is mainly due to the increasing number of cases of breast cancer. Rising awareness about breast cancer and the benefits of early detection encourages more women to undergo screening, boosting demand for DBT equipment. Governments around the region are making efforts to improve and expand healthcare services, supporting regional market growth.
| Report Attribute | Key Statistics |
| Market Revenue in 2025 | USD 4.62 Billion |
| Market Revenue by 2033 | USD 13.75 Billion |
| CAGR from 2025 to 2033 | 14.31% |
| Quantitative Units | Revenue in USD million/billion, Volume in units |
| Largest Market | North America |
| Base Year | 2024 |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
By Product
By End-user
Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/2990
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com|+1 804 441 9344
April 2025
January 2025
April 2025
May 2025